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Introduction

Abstract

Cell-mediated cytotoxicity is a process mediated
by cells of T lineage or NK lineage which ensures defence against viral infection or neoplastic transformation. Cells infected by virus or expressing tumor-specific antigens can be recognized and eliminated by cytotoxic T cells (CTL) which specifically recognize antigens in
the context of class I major histocompatibility complex
(MHC) molecules. NK cells may kill virus-infected or
transformed cells by mechanisms which are, so far, not
defined, since these cells do not express "classic" antigen receptors, such as surface lg or T cell receptor
(TcR), and exert their cytolytic function in a MHC-unrestricted fashion (Savary and Lotzova, 1986; Sprent and
Webb, 1987; Young and Cohn, 1987).
As a general rule, cell-mediated cytotoxicity is a
multistep process in which recognition, binding and killing of the target cells (TC) occur in sequence. MHC-unrestricted cytotoxic cells belong predominantly to the
NK lineage which exert their lytic activity as resting,
freshly isolated cells (Stutman, I 981; Trinchieri and
Perussia, 1984; Bonavida and Right, 1986; Herberman
etal., 1986; Kang et al., 1987; Young, 1989). The cytotoxic potential of NK cells is enhanced by Interleukin
2 (IL-2) stimulation which leads to the generation of the
so-called lymphokine activated killer (LAK) cells
(Rosemberg, 1986; Dianzani et al., 1989; Ferrini et al.,
1989). In addition, NK cytotoxicity can also be modulated or enhanced by various agents (Robertson and Ritz,
1992).
Morphologically, most cells exhibiting NK activity as well as the LAK cell precursors of T lineage are
characterized by the presence of cytoplasmic azurophilic
granules and are termed large granular lymphocytes
(LGL) (Grossi et al., 1982; Liepins et al., 1977; Grossi
and Ferrarini, 1982). In humans, cells exhibiting NK
function express multiple surface phenotypes.
Most
LGL (about 90 %) are represented by cells of CD3CD 16 + CD56+ phenotype, however, CD16- (approximately 5 %) or CD56- NK cells can also be detected
(Timonen et al., 1979; Trinchieri and Perussia, 1984;
Zarcone et al., 1987a).
Both CTL and NK/LAK cells kill their targets by

Adhesion molecules involved in the interaction
between immune system effector cells and tumor targets
are surface molecules which contribute to the formation
of cell-to-cell contacts and belong to the integrin family.
In this paper, the role played by the adhesion molecules
in the process of cell-mediated cytotoxicity is reviewed.
Furthermore, the contact area between effector and target cells has been analyzed by scanning electron microscopy. This region, termed "closed chamber", seems to
contribute to killing efficiency by creating an intimate
contact region in which cytotoxic factors can easily induce lethal hit in target cell. Thus, the extension of the
closed chamber seems to be positively related to effector
cell killing potential as well as to target cell sensitivity
and, in this context, the adhesion molecules prove to
play a pivotal role. In fact, a receptor-ligand interaction
occurs between CDlla/CD18 (LFA-1) and CD2 molecules, expressed on the effector cells, and the respective
counterparts on target cells, i.e., ICAM-1, ICAM-2, or
LFA-3. Treatment with antibodies against such molecules strongly modifies closed chamber formation without inhibiting cell-to-cell binding.
Nevertheless, in
these conditions, the killing ability of different effector
cells toward tumor targets appears to be strongly impaired. Hence, the adhesion molecules seem to be strongly
involved in the formation of the closed chamber as well
as in the activation of effector cell killing machinery.
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ated immunity and seem to be suggestive for a key role
of adhesion molecules, not only in the binding process,
but also in the activation mechanisms.

a multistage mechanism that is initiated by the binding
of the effector cell to the target cell (conjugate formation). Binding is accompanied by a rearrangement of
cell surface microvillar structures (Liepins et al., 1977;
Carpen, 1987; Arancia et al., 1991a) and cytoskeletal
structures (polarization toward the target) followed by
the activation of the effector cell and the release of
molecules (e.g., perforins) in the intercellular space capable of inducing the target cell lysis (Plaut et al., 1973;
Strom et al., 1973; Rayser et al., 1982). In this space,
the cell adhesion molecules (CAMs) such as LFA-1
(CD 1la/CD 18) and CD2, could easily interact with corresponding molecules in the target cell [e.g., ICAM-1
(CD54) and LFA-3 (CD58)] (Martz, 1987; Patarroyo et
al., 1990; Zarcone et al., 1992a). The LFA-1 protein is
a member of the integrin family that binds to the
ICAM-1 and ICAM-2 molecules, members of the immunoglobulin super-family, expressed in a wide variety of
cells from different tissues (Selvaraj et al., 1987; Boyd
et al., 1988). Binding of LFA-1 to ICAM, in addition
to the CD2-LFA-3 interaction, induces antigen-independent adhesion between effector and target cell (Springer
et al., 1987; Shaw and Shimizu, 1988; Springer, 1990).
It has been suggested that the contact region between conjugated cells, with the formation of a so-called
"closed chamber", might have an important role in the
activity of effector cells by modulating their efficiency
(Sung et al., 1986, 1988; Malorni et al., 1989; Arancia
et al., 1989, 1991a). During T cell-target cell interaction, the LFA-1 molecules co-migrate to the site of cellcell contact with the TcR molecules, but a direct binding
of LFA-1 and the TcR complex has not been demonstrated (Shaw and Luce, 1987; Takai et al., 1987). As
mentioned above, the CD2 glycoprotein on the surface
of thymocytes and T lymphocytes binds to the lymphocyte function antigen (LFA-3) on target cells and antigen-presenting cells. It has been suggested that the
physical association of CO2 and TcR complex can likely
be required for T cell triggering (Selvaraj et al., 1987;
Takai et al., 1987). Furthermore, the intimate contact
resulting from such an interaction system seems to be involved in the mechanism of cytotoxicity by improving
the "efficiency" of cytotoxic factors produced by
immune effectors and released in the contact region
(Podak, 1985; Clark, 1988; Stanley and Luzio, 1988;
Arancia et al., 1990).
In order to evaluate the role of the closed chamber features in the killing efficiency, a study has been
performed on cell surface and cytoskeleton of conjugates
formed between different effector cells and various tumor targets, by means of fluorescence microscopy and
scanning electron microscopy. In addition, a quantitative morphometric analysis has been carried out on the
structural characteristics of such a contact region. The
effect of antibodies against CAMs has also been evaluated in order to establish their involvement in the closed
chamber formation and related killing activity. Results
obtained clearly provide a general indicative method for
the evaluation of the cell-to-cell interaction in cell medi-

Materials and Methods
Cytotoxic effector cells
Several effector cell preparations were used in
this study. Peripheral blood lymphocytes (PBL) were
isolated from heparinized blood samples of normal adult
donors by Ficoll-Hypaque density gradient centrifugation
and depleted of monocytes by Percoll gradient centrifugation. Cytochemical staining for acid esterase activity
showed that monocyte contamination of PBL preparation
was always less than 3 %. PBL were used as effector
cells for the determination of NK cell-mediated cytotoxicity. For the generation of LAK cells, PBL were cultured for 3 days in RPMI 1640 (with 10% fetal calf
serum and 50 µg/ml gentamycin) containing 100 IU/ml
Interleukin 2 (IL-2) (Biogen, Lausanne, Switzerland).
For the scanning electron microscopy (SEM) analysis of conjugates formed between effector cells and
tumor cell targets (see below) we used purified populations of NK cells and of LAK cells. To this end, freshly
isolated or IL-2-cultured PBL were allowed to form high
affinity E rosettes, at 29°C, with untreated sheep erythrocytes. Non-rosetting cells were recovered by FicollHypaque density gradient centrifugation and incubated
with a mixture of anti-CD3 and anti-CD2 mouse monoclonal antibodies. Cells were subsequently admixed with
immunobeads coated with goat anti-mouse immunoglobulin (Dynabeads, Oxoid, Unipath, Milano) at a bead to
cell ratio of 40 to 1. Cells which did not adhere to the
beads were recovered and the percentage of NK cells
was evaluated by flow cytometry (FACScan, Becton
Dickinson, Mountain View, CA), following staining with
anti-CD 16 or CD56 antibodies and affinity purified,
FITC-labelled goat anti-mouse immunoglobulin antiserum (Southern Biotechnology Associates, Birmingham,
AL). Purified populations of NK and LAK cells always
contained > 80% CD16+ cells.
Tumor target cells
The NK-sensitive erythroleukemic cell line K562
(Landay et al., 1987) was used in all of the experiments.
To determine LAK activity, we used a variant of the
promyelocytic cell line HL60, HL60R, which does not
bind NK cells and consequently is NK-resistant (Zarcone
et al., 1987b). This cell line was also used as a control
for the effector to target cell binding experiments.
Antibodies
NK cells, defined as CD16+ cells, and their IL-2activated progeny were enumerated by FACS analysis
using FITC-labelled Leu 11b antibodies (Becton
Dickinson). The same antibody was employed to determine the binding of CD16+ cells to tumor targets.
Other antibodies used in these studies were directed
against CD2 (Leu 5b), CD3 (Leu 4) and CD56 (Leu 19)
(all from Becton Dickinson). The anti-LFAl (CD l la/
CD18) antibody was selected among several anti-LFA-1
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monoclonal reagents produced in our laboratory for its
ability to determine maximal inhibition of NK cellmediated cytotoxicity.
Cytotoxicity assays
NK activity was measured as the ability of fresh
PBL to lyse K562 cells. LAK activity was determined
using IL-2-cultured PBL against K562 cells or the NKresistant cell line HL60R. NK and LAK cell-mediated
cytotoxicity was determined in five distinct experiments.
The lytic function (cytotoxicity) of 30 CD3- clones was
tested against K562 cells. Target cells were labelled
with Sier by incubation with 200 µCi of Nas 1cro 4
(Amersham International, Buckinghamshire) for 1 hour
at 37°C, as described (Zarcone et al., 1989). Effector
cells were admixed with target cells at 40: 1 ratio for NK
and LAK cells and at 20: 1 ratio for CD3- cell clones.
Cell mixtures were incubated for 4 hours at 37°C in
round-bottomed 96 well microtiter plates and centrifuged
at 200 rpm for 5 minutes at the end of the incubation period. After centrifugation, 100 µl of supernatant were
harvested from each well and counted in a gamma
counter.
Spontaneous release, maximum release and %
specific Sier release were determined as previously
described (Tilden et al., 1991).
The effect of antibodies to CD16, CD56, CD2,
CDl la and CD2+CDl la on the cytotoxicity mediated
by NK cells, LAK cells and CD3- cell clones was determined through the decrease of specific Sier release and
expressed as % inhibition. Target cells were added to
the effector cells at the ratios indicated above and the 4
hour cytotoxicity assay was performed in the presence of
the antibodies.
Flow cytometric determination of NK/LAK cell
binding to tumor target cells
Percentages of CD16+ cells in freshly isolated
or IL-2-cultured PBL were determined by flow cytometric analyses after staining with FITC-labelled monoclonal
antibody (mAb) of IgM isotype (Leu 1 lb). Cells were
subsequently allowed to form conjugates with tumor
cells for an immunofluorescence binding assay. Briefly,
PBL were admixed with tumor cells (K562 or HL60R) at
5: 1 ratio and cell pellets obtained by centrifugation at
200 rpm were incubated for 10 minutes at 37°C. Pellets
were gently resuspended and analyzed by FACS. Dot
plot analyses showed two distinct cell populations consisting of unbound lymphocytes and of target cells (with
or without bound lymphocytes), respectively.
Gates
were set on the unbound lymphocyte populations and
percentages of CD 16 + cells were determined. The extent of effector to target cell binding was indicated by
decrease in the percentage of CD 16 + cells among unbound lymphocytes.
Thus, percentages of conjugateforming CD 16+ cells could be calculated. As a control
for the assay, we used the HL60R cell line, previously
shown to be unable of binding NK cells (Zarcone et al.,
1987b).
The effect of anti-adhesion molecule antibodies

was tested using the same assay. Effector cells were
separately incubated with anti-CD2, anti-CDl la/CD18
or anti-CD56 (10 mg protein/10 6 cells), or with mixtures
of these mAb, for 30 minutes on ice. Target cells were
subsequently added and the binding assay was performed
for 5 minutes at room temperature. Negative controls
were performed by using anti-Leu 19 (CD56) and antiLeu 11 (CD16), IgG l isotype (about 0.1% inhibition).
Scanning electron microscopy (SEM) analysis
For SEM analysis, conjugates between effector
and target cells were seeded on polylysine-coated coverslips. After a few minutes, to allow adhesion to the
glass surface, cells were fixed with 2.5 % glutaraldehyde
in O.lM cacodylate buffer (pH 7.4) at room temperature
for 20 minutes, post-fixed with 1 % OsO4 in the same
buffer, dehydrated through a graded ethanol series, critical-point dried with CO 2 and gold-coated by sputtering.
Samples were examined with a Philips 515 scanning
electron microscope.
Fluorescence microscopy analysis
Samples were applied to polylysine-coated glass
slides and fixed in 3 .5 % formaldehyde for 20 minutes at
room temperature.
After washing in PBS buffer, the
cells were permeated with 0.5% Triton X-100 (Sigma T6878) in the same buffer for 5 minutes at room temperature. For actin detection, cells were stained with fluorescein-phalloidin (NBD-phallacidin, Molecular Probe)
(final dilution 1:100 in PBS) at 37°C for 30 minutes.
For tubulin labelling, incubation with a mixture of
monoclonal anti-alpha and anti-beta tubulin antibodies
(Amersham) (final dilution l :500 in PBS) at 37°C for 30
minutes were performed. Washed cells were then incubated with a sheep anti-mouse IgG fluorescein-linked
whole antibody (Amersham, final dilution 1:20 in PBS).
After washing coverslips were mounted with glycerolPBS (2: 1) and analyzed with a Nikon Optiphot fluorescence microscope.
Quantitative evaluation of the conjugates contact area
In order to evaluate the extent of the contact area
between effector cells (NK, LAK) and different target
cells (K562, HL60R) conjugates were examined by
SEM. About 50 micrographs at the same magnification
(6500x) were taken for each sample. Measurements
were performed either on control conjugates or on cell
pairs after exposure to antibodies to CD2 and CD l la/
CD18. Before recording every picture, the specimen
was tilted to put the axis of the cell pair perpendicular to
the detector in order to avoid the overlapping of the two
cell types.
The length of the contact region was
determined by an interactive image analyzer (IBAS II,
Kontron), measuring the distance between the limit
points of the adhesion area between effector and target
cells. The contact area was calculated by roughly assuming it circular in shape. The mean values and the
relative standard deviations were then calculated for
each sample. The significance of the difference between
the mean values recorded in control and MoAbs-treated
conjugates was evaluated by Student's T test.
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Results and Discussion
Previous studies (Arancia et al., 1989, 1991 a)
showed that cytotoxic lymphocytes can exert a powerful
lytic activity when a wide and intimate contact area is
established with the target cell. Such a close interaction
leads to the formation of the so-called "closed chamber"
between effector and target cell, in which the various
lytic factors find ideal conditions for enhancing their
lethal potential (Zychlinsky et al., 1988; Arancia et al.,
1991a). This was also supported by morphological studies performed by comparing the interaction of effector
c~l_lswith tar~et cells displaying different NK susceptibility (Arancia et al., 1989, 1991a). In fact, in conjugates form~d with sensitive target cells, the cell pair
contact reg10ns appeared to be large and characterized
by the presence of numerous intertwined protrusions;
conversely, when resistant target cells were employed,
the contact area appeared to be narrow and no significant
involvement of the cell surface structures could be detected (Carpen 1987; Kang et al 1987; Arancia et al
199 la). Furthermore, if NK-resistant target cells forming a weak contact with NK cells, were conjugat;d with
LAK cells, an increased interaction surface was
revealed.
We report here data obtained using two different
tumor targets: the NK-sensitive K562 cell line and the
NK-resistant, LAK-sensitive, HL60R cell line. The contact area between effector and target cells has been studied by SEM and a quantitative evaluation of the extension of the contact region has been carried out. Such an
analysis revealed that a close interaction occurred between effector and target cells in both experimental conjugates examined: NK/K562 and LAK/HL60R (Figs. la
and lb, respectively).
Furthermore, the quantitative
evaluation showed that no significant difference occurred
between the two different cell pairs. In fact, the average
length of the closed chamber in NK/K562 conjugates was
about 4.01 µm with respect to 3.53 µm measured in
LAK/HL60R pairs (Fig. 2). The cell contact area was
calculated by assuming it to be circular and smooth.
However, it is known that the cell surface of both effector and target cells is characterized by numerous intertwined microvilli and invaginations in the contact region. Thus, it is not possible to measure the real extent
of the adhered cell membranes.
Several studies have been carried out to investigate the involvement of the cytoskeletal components in
the binding and killing processes (Plaut et al. 1973·
Sirianni et al., 1988; Malorni et al., 1989; Ar~ncia e~
al., 1991a). In fact, the configuration of the intercellular space between effector and target cell also depends
on the cytoskeletal arrangement of both cell types. In
particular, the binding of the NK or LAK cells to the
target ~el!s depends on microfilaments, whereas target
cell lys1s 1s known to require microtubule assembly and
rearrangement in both effector and target cells (Kupffer
et al., 1983; Kupffer and Dennert, 1984; Sirianni et al.,
1988; Arancia et al., 1991a). In this context, the role of
the target cell in the interaction with the effector cell has

also to be evaluated. An "induced suicide" model has
been suggested by Ucker (1987) who hypothesized a suicide pro~ram that can be activated in the target cell by
several different stimuli. Other authors also focused on
the possibility of the target cell playing a direct role in
its own death (Russel, 1983; Goldstein, 1987; Pitsillides
et al., 1988; Chayen et al., 1990). Thus, different susceptibilities found in the tumor target cells could also
depend on a different suicide program and different
degree of "permissiveness"
in allowing their death
(Suthanthiran et al., 1984; Kramer and Simon, 1987).
Moreover, these data indicated that the target cell contributes actively in determining the formation of an extended and intimate contact with the killer cell (Kang et
al. 1987; Arancia et al., 1991a). The changes occurring
in cytoskeletal elements of target cell seem to support
the challenging opinion of an induced suicide mechanism. In fact, the lytic process seems to occur differently in the conjugated target cells studied by an ultrastructural SEM analysis. A cell surface phenomenon, known
as b!e_bbing, is easily appreciated in K562 cells, highly
sens1t1ve to NK activity (Fig. 3a). By contrast, the NKresistant HL60R cells, even though recognized and
bound by effector cells, undergo surface smoothing and
appear to be simply adjacent to the killer cells (Fig. 3b).
Blebbing process, widely recognized as a peculiar marker of injured or dying cells, was usually associated with
ion deregulation and free radical formation (Allen, 1987;
Bellomo et al., 1990; Malorni et al., 1991a). The finding that OH scavengers inhibit NK cell activity, suggested that OH, possibly generated via the lipooxygenase
pathway of arachidonic acid metabolism, can contribute
directly to target cell lysis or to being generated in the
inter-plasma membrane space between target cells and
effector cells (Suthanthiran et al., 1984). These data
can also be related to recent results which involve target
cell triggering by exogenous mechanisms (Di Virgilio et
al., 1990). However, dying target cells showing different sensitivity to immune effectors exhibit different morphological features which could probably be further important markers of cell behaviour in terms of susceptibility (Liepins et al., 1977; Arancia et al., 1989). This
could also depend on the availability of different targets
to be "turned on" in their "suicide program"-cascade.
To evaluate the role played by the adhesion molecules in the formation of the closed chamber and to verify if the cell-to-cell interaction could be modified by
altering CAM function, the NK and LAK cells were incubated with anti-CD2 or anti-LFA-1 monoclonal antibodies (alone or in association) before conjugation with
the different target cells. In fact, some studies hypothesized that antibodies to CAMs expressed on the target
cells or on the effector cells inhibit, to a variable extent,
the target cell lysis induced by both CTL and NK/LAK
cells (Robertson et al., 1990; Springer, 1990; Van
Seventer et al., 1990). The general hypothesis on the
n:iechanism of such inhibition was that it depends primanly on a reduced binding, i.e., pair number, or to an altered conjugate formation, i.e., an impairment of inter-
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Figure 1. NK/K562 (a) and LAK/HL60R (b) conjugates
observed by SEM. In both cases, a wide and intimate
contact region is established between effector (to the
right) and target cells (to the left). Bars = 10 µm (Fig.
la) and 5µm (Fig. lb).
K 562

4.01!121

p<001

pm

NK
(Abs)

Figure 2. Scheme showing the average length of the
contact region in the various cell pairs examined. In
both cell conjugates (NK/K562 and LAK/HL60R) the extent of the cell-to-cell contact appears to be significantly
reduced after treating the effector cells with anti-CD2
and anti-CD l la/CD 18 monoclonal antibodies.

K562

297!:0BSpm

Figure 3. Morphological aspects of the target cell death
after binding with NK cell. K562 cells, highly sensitive
to NK activity, undergo lysis by showing an evident surface blebbing phenomenon (a). In NK-resistant HL60R
cells the surface blebbing was not observed and the
dying cells showed a surface smoothing with a complete
loss of microvilli (b). Bars = 10 µm (Fig. 3a) and 5µm
(Fig. 3b).

p<<0.01
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cellular contact. In our experience, when LAK cells
were incubated with anti-CAM antibodies before conjugation with the target cells (HL60R), most cell pairs
showed a modification of the closed chamber features resulting in a remarkable reduction and narrowing of contact surface which became sometimes "punctiform" (Fig.
4). In particular, a reduction of effector cell cytotoxicity, but not of binding, was detected after exposure to
anti-CAMs either if administered solely or in combination. However, when treatment was performed with
both antibodies the effector cell function appeared even
more impaired (Table 1). The same effect was obtained
in NK-K562 conjugates, albeit to a lesser extent.
The quantitative morphometric evaluation performed on SEM images showed statistically significant
differences between control and antibody treated samples
(Fig. 2). In particular, in NK-K562 conjugates the average cell contact area appears to be reduced of about one
haif after preincubation of effector cells with anti-CD2
and anti-LFA-1 antibodies. In LAK-HL60R conjugates
this effect was even more evident, the cell contact area
resulting to be about one third in antibody-treated samples when compared to control ones (Fig. 5).
Results obtained seem to suggest that both CD2
and LFA-1 play an important role in the mechanism of
interaction and that the combined action of these two
surface molecules contributes to the formation of a wide
"closed chamber" between effector and target cell, probably improving killing ability. In fact, the pretreatment
of both resting and IL-2-activated NK cells with antibodies to LFA-1 and CD2, alone or in combination, appeared to yield the highest level of inhibition. However,
there are large differences in the level of inhibition
which appear to be related to the degree of target cell
sensitivity to NK/LAK cells. In conciusion, the killing
process, rather than binding, seems to be a CAM-dependent phenomenon.
Treatment of NK and LAK cells with antibodies
to CD2 and LFA-1 produces modifications only in the
microtubule network when compared to control effector
cell/target cell pairs.
In fact, actin microfilaments
appear to be marginalized in both control (Fig. 6a) and
MoAbs exposed effector cells (Fig. 6b). In contrast, microtubular apparatus appears to be polarized toward target cell in control conjugates only (Fig. 6c), whereas it
appears to be diffuse in pairs from MoAbs exposed effectors (Fig. 6d). These data are in accord with the
functional results above mentioned and strongly suggest
a role of adhesion molecules not merely in the binding
process but in the killing too (Bierer et al., 1989; Figdor
et al., 1990; Makgoba et al., 1988, 1989; Springer,
1990; Van Seventer et al., 1990). The changes in the
cytoskeletal arrangement observed in the effector cell
treated with MoAbs, after binding with the target cell,
seem in fact to contribute to both the important aspects
of the cytotoxic mechanism: the formation of a close
cell-to-cell contact between effector and target cell but,
most of all, the delivery of the lytic substances against
the target cell.
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target cell pairs as revealed by fluorescence microscopy. Actin microfilaments appear to be marginalized in both control (a) and MoAbs-treated effector cells (b). In contrast, the microtubular apparatus appears to be polarized toward
target cell in control conjugates (c) and to be diffused in pairs from MoAbs-treated effector cells (d). Bar = 10 µm.
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Discussion with Reviewers

E. de Harven:
Was the effect of antibodies demonstrated to be dose-dependent, and what irrelevant antibodies were used as controls in these experiments?
Y .H. Kang: The authors do not mention how much of
each antibody was used to inhibit the cytotoxicity of NK
cells and LAK cells. The authors also did not address
whether the inhibition by the antibodies is dose-related.
Authors: Antibody concentrations were those used in
immunofluorescence assays for staining cells, i.e., 10
mg protein/ 106 cells. More importantly, this concentration represents the plateau dose for efficient inhibition of
cytotoxicity. Negative controls were performed by using
anti-Leu 19 (CD56) and anti-Leu 11 (CD16), IgGl isotype (about 0.1 % inhibition).
E. de Harven: You appropriately described cell-mediated cytotoxicity as a multistep process. Surprisingly,
the time factor is barely mentioned in your experiments.
Are the "conjugates" observed by SEM 2, 10, 30 or 120
minutes after the effector cells (NK or LAK) have had
an opportunity to make contact with the target cells?
Admittedly, it is difficult to precisely synchronize the
encounter between effector and target cells. However,
if all the SEM observations are made at one arbitrarily
chosen time after conjugation, please explain the rationale for such a static approach to the study of a dynamic
cell-cell interaction process.
Authors: The binding phase occurs in seconds to minutes, the killing phase in minutes to hours. We think

W. Malorni et al.
that a time course study would be interesting but not
useful considering the ability of the effectors to "recycle" themselves continuously to kill their targets. In
our opinion, such a study would refer to the conjugation
process per se. Different incubation times (30 minutes,
1, 2 and 4 hours) were in fact used. Unfortunately, conjugate formation, once it is occurring, proceeds continuously.

speci fie antibodies were used?
Authors: NK cells were purified by negative selection
using B and T cell depletion with anti-CD3 and CD19
antibodies following treatment with complement or magnetic beads. Monocytes were previously eliminated by
Percoll gradients.
Y .H. Kang: What is the definition of "closed chamber"? Is this term created by the authors based on their
own ultrastructural observations? Ultrastructure of the
NK-K562 conjugates does not really reveal that the contacts between NK cells and K562 target cells form a
chamber-like structure.
Authors: The term "closed chamber" was used in order
to define the contact region between effector cells and
target cells. In this region, a wide intertwining of microvillous structures leads to the formation of a sort of
chamber in which perforins as well as other "cytotoxic"
factors can easily reach the target cell with minimal dispersion in the environment. We think that SEM analysis
can provide useful information about this region. Kang
et al. (1987) have used transmission electron microscopy
(TEM) to analyze effector-target cell conjugates. Under
these circumstances only a study of serial sections may
define the existence, or not, of a closed chamber. Otherwise, the effector/target cell contacts are selected at
random.

L.H. Graf: Under the experimental conditions employed, CD2 and LFA-1 of the effector cells do not
seem to contribute in a major way to the formation of
the observed conjugates. In the case of the temperatureand Mg2+ -dependent formation of conjugates between
ICAM-1 and LFA-1 (Mac-1), the incubation conditions
(room temperature, unspecified Mg2+ concentration)
might be a factor. Information about the percents of
CD16+ cells involved in the conjugates in the absence of
antibodies (Abs) would be useful, as the possibility that
the experimental conditions are not permitting a physiologically critical component of effector to target recognition to occur, hence allowing only "backup" adhesion
mechanisms to be studied, must be considered.
E. de Harven: Cells were incubated with anti-adhesion
molecule antibodies for one hour at room temperature.
How much of these Abs/CAM complex is already internalized at that time? And, if most of these complexes
are already internalized, how could the CAM molecules
still be determinant facts in the subsequent binding
assays you performed?
Authors: In the conjugate formation assay and in order
to determine the effect of antibodies, we proceeded as
follows: Effector cells were incubated with antibodies
to CD2 and LFA-1 for 30 minutes on ice and subsequently mixed with target cells. The target-effector mixture was pelleted and incubated at room temperature for
5 minutes. The mixture was resuspended and conjugates
were counted. In these conditions, the percentage of
conjugate-forming cells was unchanged as compared to
controls. Our observations according to the literature
data indicate that 50- 70 % of CD 16-positive cells are
capable of forming a conjugate with K562 cells under
the experimental conditions describe above (see also
Zarcone et al., 1992). We also agree that several other
ligand-receptor pairs may influence the binding of effectors to target cells as is also suggested by our recent
studies (Zarcone et al., 1992).

Y .H. Kang: The authors assume that the contacts between effector and target are circular.
How did the
authors derive such an assumption?
Authors: We think that two spherical cells could only
interact by forming a round-shaped contact area, as
revealed by SEM or light microscopy (including confocal microscopy). Only serendipity could provide such an
image in a singe section in a TEM (see Liepins et al.,
1977, or Carpen, 1987).
Y .H. Kang: The authors intend to correlate their observations on the alterations in the organization of actin
filaments and microtubules in both effector cells and target cells with the lytic process. The reorganization of
actin filaments is known to be regulated by surface integrins. The authors do not mention the effect of the antiCAM antibodies (anti-LFA-1) on the reorganization of
actin filaments. In this respect, does anti-ICAM-1 antibody affect the reorganization of the cytoskeleton and
result in impairment of "close chamber" formation and
killing?
ICAM-1 is a specific ligand for LFA-1
receptor.
Authors:
Papers by Kupffer and colleagues, e.g.,
Kupffer et al. (1989), and by our group (Arancia et al.,
1985, 1989, 1991a, 1991b; Malorni et al., 1987, 1989,
1991b; Sirianni et al., 1988; Zarcone et al., 1992a,
1992b) have tried to approach this question of "dynamic
changes" occurring in two cells capable of binding themselves and interacting so closely.

Y .H. Kang: Which target or tumor cells express CD54?
Authors: We refer you to Table 1 in Zarcone et al.
( 1992) for the expression of adhesion molecules on
tumor cell targets.
Y .H. Kang: Do some tumor tissues also express integrins? If so, what cells?
Authors: For this important question, please refer to
papers by R.O. Hynes (Hynes, 1987, 1992).
Y .H. Kang:

How were NK cells purified?

Which NK-

332

